Published in Gene Therapy Weekly, August 17th, 2000
This technology essentially renders the body transparent and will allow physicians to determine whether gene therapies reach targeted cells and work as they should.
"Basically, we've found a way to make the body transparent for gene therapy. No matter what gene therapy we give to a patient, we will be able to follow what it's doing and know if it's working safely and effectively," said Dr. Sanjiv Gambhir, a researcher at UCLA's Jonsson Cancer Center. "Until now, there's been no reliable...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2000-08-17)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.